Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Dna Scns
(NQ:
APDN
)
0.4400
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,928
Open
0.4400
Bid (Size)
0.4400 (10)
Ask (Size)
0.4500 (2)
Prev. Close
0.4400
Today's Range
0.4400 - 0.4400
52wk Range
0.3680 - 1.860
Shares Outstanding
16,978,703
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start
March 18, 2024
Via
ACCESSWIRE
Performance
YTD
-29.04%
-29.04%
1 Month
-35.39%
-35.39%
3 Month
-32.35%
-32.35%
6 Month
-67.41%
-67.41%
1 Year
-58.10%
-58.10%
More News
Read More
Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress
March 14, 2024
Via
ACCESSWIRE
Recap: Applied DNA Sciences Q1 Earnings
February 08, 2024
Via
Benzinga
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
February 08, 2024
Via
ACCESSWIRE
Earnings Scheduled For February 8, 2024
February 08, 2024
Via
Benzinga
Earnings Preview For Applied DNA Sciences
February 07, 2024
Via
Benzinga
Applied DNA Sciences: Q4 Earnings Insights
December 07, 2023
Via
Benzinga
Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
December 07, 2023
Via
ACCESSWIRE
Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
November 16, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
February 05, 2024
Via
Benzinga
Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
February 05, 2024
Via
ACCESSWIRE
Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 02, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 31, 2024
Via
Benzinga
Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform
November 09, 2023
Via
ACCESSWIRE
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 31, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 18, 2023
Via
Benzinga
Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
December 14, 2023
Via
ACCESSWIRE
Lululemon To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
December 08, 2023
Via
Benzinga
APDN Stock Earnings: Applied DNA Sciences Beats EPS, Misses Revenue for Q4 2023
December 07, 2023
Via
InvestorPlace
Earnings Scheduled For December 7, 2023
December 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 06, 2023
Via
Benzinga
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
December 05, 2023
Via
ACCESSWIRE
Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
November 28, 2023
Via
ACCESSWIRE
Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
September 14, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.